Drug Shortage Report for AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Report ID | 125395 |
Drug Identification Number | 02470780 |
Brand name | APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN |
Common or Proper name | APO-TRI-PACK HP |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE AMOXICILLIN CLARITHROMYCIN |
Strength(s) | 30MG 500MG 500MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET |
Route of administration | ORAL ORAL |
Packaging size | 56 BLS |
ATC code | A02BD |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-11-30 |
Actual start date | 2020-12-01 |
Estimated end date | 2021-07-16 |
Actual end date | 2021-06-18 |
Shortage status | Resolved |
Updated date | 2021-06-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-06-21 | French | Compare |
v13 | 2021-06-21 | English | Compare |
v12 | 2021-06-15 | French | Compare |
v11 | 2021-06-15 | English | Compare |
v10 | 2021-04-16 | French | Compare |
v9 | 2021-04-16 | English | Compare |
v8 | 2021-03-08 | French | Compare |
v7 | 2021-03-08 | English | Compare |
v6 | 2021-03-08 | French | Compare |
v5 | 2021-03-08 | English | Compare |
v4 | 2020-12-01 | English | Compare |
v3 | 2020-10-01 | French | Compare |
v2 | 2020-10-01 | English | Compare |
v1 | 2020-10-01 | English | Compare |
Showing 1 to 14 of 14